Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Journal of Neurology|February 28, 2007
Paraneoplastic diseases associated with thymomaAmelia Evoli, Giacomo Maria Minicuci, Roberta Vitaliani, et al.Cancer Immunology, Immunotherapy : CII|January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.Immunology|November 25, 2003
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoireAlessandra Battaglia, Gabriella Ferrandina, Alessia Buzzonetti, et al.Journal of Clinical Immunology|November 15, 2007
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapyAndrea Fattorossi, Alessandra Battaglia, Alexia Buzzonetti, et al.Immunology|November 22, 2007
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Giovanni Monego, et al.Immunology|January 3, 2013
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell developmentAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.Cancer Immunology, Immunotherapy : CII|January 4, 2020
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patientsAlessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.Cancer Immunology, Immunotherapy : CII|March 29, 2020
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patientsAlessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.Translational Oncology|February 16, 2018
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian CancerEnrica Martinelli, Andrea Fattorossi, Alessandra Battaglia, et al.Pageof 4